Clinical trials
Phase 1 Multiple Myeloma trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
829 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 5 |
| 2001 | 7 |
| 2002 | 8 |
| 2003 | 14 |
| 2004 | 12 |
| 2005 | 20 |
| 2006 | 17 |
| 2007 | 23 |
| 2008 | 37 |
| 2009 | 22 |
| 2010 | 21 |
| 2011 | 23 |
| 2012 | 33 |
| 2013 | 22 |
| 2014 | 42 |
| 2015 | 34 |
| 2016 | 25 |
| 2017 | 40 |
| 2018 | 37 |
| 2019 | 45 |
| 2020 | 39 |
| 2021 | 54 |
| 2022 | 48 |
| 2023 | 37 |
| 2024 | 49 |
| 2025 | 35 |
| 2026 | 51 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 382 |
| Terminated | 134 |
| Recruiting | 106 |
| Unknown status | 79 |
| Active, not recruiting | 55 |
| Not yet recruiting | 39 |
| Withdrawn | 29 |
| Suspended | 5 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| National Cancer Institute (NCI) | 31 |
| Celgene | 25 |
| Memorial Sloan Kettering Cancer Center | 18 |
| Washington University School of Medicine | 17 |
| AbbVie | 14 |
| Mayo Clinic | 14 |
| Novartis Pharmaceuticals | 14 |
| Institute of Hematology & Blood Diseases Hospital, China | 13 |
| Janssen Research & Development, LLC | 13 |
| Amgen | 12 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Multiple Myeloma | 829 |
| Lymphoma, Non-Hodgkin | 125 |
| Recurrence | 112 |
| Neoplasms, Plasma Cell | 106 |
| Leukemia, Lymphocytic, Chronic, B-Cell | 99 |
| Lymphoma | 96 |
| Leukemia, Myeloid, Acute | 95 |
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 93 |
| Hodgkin Disease | 89 |
| Lymphoma, Large B-Cell, Diffuse | 85 |
Trials
Showing 1 to 25 of 829. Each trial links to its page on Pharma Observatory.
729 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.